{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:50:46Z","timestamp":1792803046587,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2020YFC2009006"],"award-info":[{"award-number":["2020YFC2009006"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","award":["LHGJ20210494"],"award-info":[{"award-number":["LHGJ20210494"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31471330"],"award-info":[{"award-number":["31471330"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.heliyon.2023.e18046","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T12:46:11Z","timestamp":1689079571000},"page":"e18046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Oridonin impedes breast cancer growth by blocking cells in S phase and inhibiting the PI3K\/AKT\/mTOR signaling pathway"],"prefix":"10.1016","volume":"9","author":[{"given":"Weijie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youcai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.heliyon.2023.e18046_bib1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4252\/wjsc.v13.i7.841","article-title":"Stem cell therapy: a paradigm shift in breast cancer treatment","volume":"13","author":"Khan","year":"2021","journal-title":"World J. Stem Cell."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18046_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00404-015-3859-y","article-title":"An overview of triple-negative breast cancer. Archives of gynecology and obstetrics","volume":"293","author":"Kumar","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e18046_bib3","first-page":"1339","article-title":"Treatment of breast cancer. American family physician","volume":"81","author":"Maughan","year":"2010","journal-title":"Am. Fam. Physician"},{"issue":"7351","key":"10.1016\/j.heliyon.2023.e18046_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature10212","article-title":"Microenvironmental regulation of stem cells in intestinal homeostasis and cancer","volume":"474","author":"Medema","year":"2011","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.heliyon.2023.e18046_bib5","first-page":"2","article-title":"Study on modern pharmacological and chemical components and clinical medication of Isodon rubescens. Inner Mongolia traditional","volume":"33","author":"Xiong","year":"2014","journal-title":"Chin. Med."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e18046_bib6","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1111\/jcmm.15106","article-title":"Oridonin inhibits the migration and epithelial-to-mesenchymal transition of small cell lung cancer cells by suppressing FAK-ERK1\/2 signalling pathway","volume":"24","author":"Xu","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.heliyon.2023.e18046_bib7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.biopha.2018.02.011","article-title":"Oridonin inhibits oral cancer growth and PI3K\/Akt signaling pathway","volume":"100","author":"Yang","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e18046_bib8","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1002\/jcb.27654","article-title":"Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K\/AKT\/mTOR and Ras\/Raf pathways","volume":"120","author":"Jiang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.heliyon.2023.e18046_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ejmech.2019.06.006","article-title":"Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells","volume":"178","author":"Luo","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18046_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12032-014-0365-1","article-title":"Oridonin phosphate-induced autophagy effectively enhances cell apoptosis of human breast cancer cells","volume":"32","author":"Li","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.heliyon.2023.e18046_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104313","article-title":"Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects","volume":"146","author":"Li","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18046_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metabol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e18046_bib13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nbt.4101","article-title":"Metabolomics activity screening for identifying metabolites that modulate phenotype","volume":"36","author":"Guijas","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18046_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ptr.6829","article-title":"Oridonin induces ferroptosis by inhibiting gamma-glutamyl cycle in TE1 cells","volume":"35","author":"Zhang","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.heliyon.2023.e18046_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-physiol-020518-114455","article-title":"Branched chain amino acids. Annual review of physiology","volume":"81","author":"Neinast","year":"2019","journal-title":"Annu. Rev. Physiol."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e18046_bib16","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/nm.3686","article-title":"Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development","volume":"20","author":"Mayers","year":"2014","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18046_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbrc.2017.02.101","article-title":"Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function","volume":"486","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e18046_bib18","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","article-title":"mTOR signalling and cellular metabolism are mutual determinants in cancer","volume":"18","author":"Mossmann","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e18046_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.15430\/JCP.2021.26.4.237","article-title":"Role of branched-chain amino acid metabolism in tumor development and progression","volume":"26","author":"Jung","year":"2021","journal-title":"Journal of cancer prevention, J Cancer Prev."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e18046_bib20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/s41429-021-00438-x","article-title":"Natural products targeting cancer cell dependency","volume":"74","author":"Shi","year":"2021","journal-title":"J. Antibiot."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e18046_bib21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.gendis.2020.06.010","article-title":"Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance","volume":"8","author":"Liu","year":"2020","journal-title":"Genes Dis"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18046_bib22","first-page":"64","article-title":"Branched-chain amino acid metabolism in cancer","volume":"21","author":"Ananieva","year":"2018","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e18046_bib23","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1042\/BCJ20190754","article-title":"Leucine and branched-chain amino acid metabolism contribute to the growth of bone sarcomas by regulating AMPK and mTORC1 signaling","volume":"477","author":"Martin","year":"2020","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e18046_bib24","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cmet.2018.12.020","article-title":"Loss of BCAA catabolism during carcinogenesis enhances mTORC1 activity and promotes tumor development and progression","volume":"29","author":"Ericksen","year":"2019","journal-title":"Cell Metabol."},{"issue":"7680","key":"10.1016\/j.heliyon.2023.e18046_bib25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature24294","article-title":"BCAT1 restricts \u03b1KG levels in AML stem cells leading to IDHmut-like DNA hypermethylation","volume":"551","author":"Raffel","year":"2017","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e18046_bib26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nm.3217","article-title":"BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1","volume":"19","author":"T\u00f6njes","year":"2013","journal-title":"Nat. Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023052544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023052544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T19:05:15Z","timestamp":1766171115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023052544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2405844023052544"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18046","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oridonin impedes breast cancer growth by blocking cells in S phase and inhibiting the PI3K\/AKT\/mTOR signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e18046"}}